CSA Medical said yesterday that it put a $23 million debt-and-equity round on ice for the cryospray technology it’s developing. Boston-based CSA said Horizon Technology Finance led the round with a $15 million loan facility; existing shareholders ponied up $8 million in equity financing, the company said. The round’s first tranche included a $6 million loan from […]
CSA Medical touts QoL improvements in RejuvenAir chronic bronchitis study
CSA Medical today released early results from a feasibility study exploring the use of its RejuvenAir Metered Cryospray system in treating patients with chronic bronchitis, touting improvements in quality of life for patients treated with the system. Results from the trial were presented at the 2018 European Respiratory Society Congress in Paris, the Boston-based company said. […]
7 medtech stories we missed this week: Dec. 8, 2017
From Minimus Spine’s European distribution deal to Stimwave receiving FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Minimus Spine inks EU distribution deal Minimus Spine announced in a Dec. 4 press release that it has signed its first European distribution deal with Italian company Moss […]
First patient treated with CSA Medical’s AV spray catheter
CSA Medical said today that the first patient was treated using the company’s new rapid AV spray catheter for the management of persistent symptomatic esophageal cancer and associated dysplastic Barrett’s disease. The device uses a stainless steel catheter wall to cut the time needed to deliver liquid nitrogen spray to the treatment site by 50%, the […]
CSA Medical wins another FDA expansion for TruFreeze cryotherapy
Endoscopic cryo-ablation company CSA Medical said today it won expanded FDA 510(k) clearance for its TruFreeze spray cryotherapy system, now cleared for use on patients with Barrett’s esophagus with low grade dysplasia. With the clearance, the device is now approved for both low and high grade dysplasia as well as malignancies, the Boston-based company said. “Over the […]
CSA Medical wins expanded FDA nod for TruFreeze system
Endoscopic cryo-ablation company CSA Medical said today it won FDA 510(k) clearance for a 3rd spray kit, the rapid AV spray kit, for its TruFreeze system. The Boston-based company’s TruFreeze system is designed as a cryosurgical tool designed for use in dermatology, gynecology, general surgery and to ablate benign and malignant lesions. The newly cleared addition is […]
Acelity taps Jokinen as CFO, exec VP | Personnel Moves June 20, 2017
Acelity said last week it tapped Tracy Jokinen as its chief financial officer and executive vice president, taking over for interim CFO Todd Wyatt. Jokinen was formerly a CFO of uniform and facility services provider G&K services, which was acquired by Cintas earlier this year. Prior to working at G&K, Jokinen spent more than 20 years at […]
CSA Medical raises $6.6m
Endoscopic cryo-ablation company CSA Medical has raised $6.6 million in a new financing round, according to an SEC filing. The Baltimore, Md.-based company’s main product is the TruFreeze spray cryotherapy device, designed to deliver super-cold liquid nitrogen via catheter to ablate unwanted tissue, according to CSA. The company’s latest round had 26 unlisted investors, with CSA […]
Medtech investment in MN falls back to earth | Medtech funding for the week of April 20, 2015
CSA Medical raises another $4m for cryotherapy device
Maryland’s CSA Medical said last week that it’s close to reaching a $4 million funding goal with a new debt offering.
CSA Medical closes $16M financing round
CSA Medical said it raised $16 million, closing a series C financing round led by Ascension Ventures.
The Baltimore-based medical device company manufactures advanced spray cryotherapy technology that flash freezes unwanted tissue inside the body, delivering liquid nitrogen through a catheter.
MassDevice Network
@MassDevice
LinkedIn